SP
Sofinnova Partners
Venture CapitalActiveSofinnova Partners is an independent venture capital firm based in Paris, France.
229
Investments
10
Exits
$2.5B
AUM
4.4%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Sofinnova Partners.
Investment Thesis & Strategy
Sofinnova Partners is a venture capital firm that invests in various stages of fintech and venture capital companies. They are based in Paris, France.
Investment Activity
Deals per year over the last 12 years
1
20060
20070
20080
20091
20100
20111
20121
20133
20142
20150
20162
2017Portfolio Companies
Selected investments from their portfolio of 229 companies
A
Actelion
Biotech · Growth, 0
M
Minoryx Therapeutics
Biotech · Series B, 2017
M
MaaT Pharma
Biotech · Series A, 2017
H
Hookipa Pharma
Biotech · Series A, 2015
O
OSE Immunotherapeutics
Biotech · Series A, 2015
G
GenSight Biologics
Biotech · Series A, 2014
I
Inventiva
Biotech · Series A, 2014
H
Horama
Biotech · Series A, 2014
P
Pixium Vision
Biotech · Series A, 2013
D
DBV Technologies
Biotech · Series A, 2012
C
Carmat
Biotech · Series A, 2010
V
Valneva
Biotech · Growth, 2006
Notable Exits
CompanyTypeYearValue / Acquirer
ActelionAcquisition2017$30B
MedDay PharmaceuticalsAcquisition2017—
GenSight BiologicsIPO2016—
DBV TechnologiesIPO2014—
Pixium VisionIPO2014—
EOS imagingIPO2014—
Stallergenes GreerIPO2011—
CarmatIPO2010—
Kiadis PharmaIPO2007—
Innate PharmaIPO2006—
Frequently Asked Questions
Sofinnova Partners focuses on Series A, Series B, Series C+ stage investments.